Disseminated Saprochaete capitata in a patient with Diabetes mellitus and HCV Hepatitis; A Case Report


  • Jamal Ahmad Wadi Al Ramahi M.D, FIDSA Office 11, The Medical Center, Jordan Hospital and medical Center 29 Adeeb Wahbeh Street Amman - Jordan 11118
  • Walid Jamal
  • Mustafa Alaskar




Saprochaete capitata, hematological malignancy, yeast, antimicrobials exposure, antifungal resistance.


Saprochaete capitata yeast rarely causes human infections; nonetheless the vast majority of infections were reported in patients with hematological malignancy. Here, we report one of the unusually rare presentations of disseminated Saprochaete capitata in a patient without hematological malignancy, but the patient had a prolonged history of chronic active hepatitis C, diabetes mellitus, prolonged ICU stay on mechanical ventilation, and exposure to several antimicrobials. The currently isolated Saprochaete capitata showed resistance to Amphotericin B, triazoles and ecchinocandins, but susceptible to 5-fluocytocine with MIC ≤1 mg/dl.

Author Biography

Jamal Ahmad Wadi Al Ramahi M.D, FIDSA, Office 11, The Medical Center, Jordan Hospital and medical Center 29 Adeeb Wahbeh Street Amman - Jordan 11118

Chairman, The Infection Prevention and Control Committee

Al Khalidi Medical Center


- Ivannah Pottier, Stéphanie Gente, Jean-Paul Vernoux, Micheline Guéguen. Safety assessment of dairy microorganisms: Geotrichum candidum. International Journal of Food Microbiology 2008 September 1;126(3):327–332

- S. Mazzocato, E. Marchionni, A. W. Fothergill, D. A. Sutton, S. Staffolani, et al. Epidemiology and outcome of systemic infections due to saprochaete capitata: case report and review of the literature. Infection 2014 July. DOI:10.1007/s15010-014-0668-3

- Villa López I, Doblas Claros A, Saavedra JM, Herrera-Carranza M. Multi-organ failure in a patient with fungaemia due to Saprochaete capitata. Revista Iberoamericana de Micologia 2013;30(4):261-263. DOI: 10.1016/j.riam.2012.12.003

- Juan Carlos García-Ruiz, Leyre López-Soria, Iñigo Olazábal, Elena Amutio, Inés Arrieta-Aguirre, et al. Invasive infections caused by Saprochaete capitata in patients with haematological malignancies: Report of five cases and review of the antifungal therapy. Revista Iberoamericana de Micología Micología 2013 October -Decemebr;30(4):248-255

- Naveen Pemmaraju, Aditya V. Shetty, Victor G. Prieto, Nitin Jain, Dimitrios P. Kontoyiannis and Gautam Borthakur. Disseminated Saprochaete capitata (formerly known as Geotrichum capitatum and Blastoschizomyces capitatus) in a patient with acute myeloid leukemia. European Journal of Haematology 2014 December;93(6):543–544

- Muriel Picard, Sophie Cassaing, Philippe Letocart, Xavier Verdeil, Caroline Protin, et al. Concomitant cases of disseminated Geotrichum clavatum infections in patients with acute myeloid leukemia 2014 mBio May;55(5):1186-1188. doi:10.3109/10428194.2013.820290.

- Prashant Purohit, Inam Al-Obaid, Ebtesam Al-Oneizi, Osama Al-Hindi, Leena Joseph, et al. Breakthrough disseminated Saprochaete capitata infection in a child with acute myeloid leukaemia receiving caspofungin therapy. JMM Case Reports 2014. DOI 10.1099/jmmcr.0.001750

- C. Schuermans, M. van Bergen, L. Coorevits, J. Verhaegen, K. Lagrou, et al. Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature. Med Mycol 2011; 49 (4): 414-418. doi: 10.3109/13693786.2010.535179

- Marisa Z. R. Gomes, Ying Jiang, Victor E. Mulanovich, Russell E. Lewis, Dimitrios P. Kontoyiannisa. Effectiveness of Primary Anti-Aspergillus Prophylaxis during Remission Induction Chemotherapy of Acute Myeloid Leukemia. Antimicrob Agents Chemother 2014 May;58(5):2775–2780

- Emilio Bouza, Patricia Muñoz. Epidemiology of candidemia in intensive care units. International Journal of Antimicrobial Agents 2008 November;32:S87–S91

- Henry M. Blumberg, William R. Jarvis, J. Michael Soucie, Jack E. Edwards, Jan E. Patterson, et al, and the NEMIS Study Group. Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study. Clin Infect Dis 2001; 33:177–86

- Matthew Morrell, Victoria J. Fraser and Marin H. Kollef. Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality. Antimicrob. Agents Chemother. 2005 September;49(9): 3640-3645







Most read articles by the same author(s)